KPMG Corporate Finance LLC (KPMG CF) acted as the exclusive financial advisor to Medusind Solutions, Inc. on its strategic investment from H.I.G. Capital (“H.I.G.”).
Medusind is a leading provider of comprehensive end-to-end revenue cycle management (“RCM”) solutions including practice management, eligibility, coding, claims processing and value-added analytics. The Company’s medical expertise and technology solutions optimize the healthcare revenue cycle process, create operating efficiencies and ensure adherence to regulatory compliance requirements.
H.I.G. is a leading global private equity and alternative assets investment firm with over $30 billion of equity capital under management. Since its founding in 1993, H.I.G. has invested in and managed more than 300 companies worldwide. The firm’s current portfolio includes more than 100 companies with combined sales in excess of $30 billion.
The global Corporate Finance practices of KPMG International’s network of independent member firms was ranked #1 as the top M&A middle-market adviser globally by Refinitiv, based on number of completed transactions, for 2018.
KPMG Corporate Finance LLC was recently named Transaction Advisory Firm of the Year by The Global M&A Network, and previously named Investment Bank of the Year by The M&A Advisor. KPMG Corporate Finance LLC provides a broad range of investment banking and advisory services to its domestic and international clients. Our professionals have the experience and depth of knowledge to advise clients on global mergers and acquisitions, sales and divestitures, buyouts, financings, debt restructurings, equity recapitalizations, infrastructure project finance, capital advisory, portfolio solutions, fairness opinions, and other advisory needs.